US authorities are investigating the death of another woman who received the Johnson & Johnson (J&J) COVID-19 vaccine. This was announced on Thursday, April 22, by ABC broadcaster, citing the Oregon Department of Health.
This is a 50-year-old patient who was vaccinated with a vaccine developed by J&J division, Janssen, in early April. According to the authorities, the woman died as a result of blood clots.
On April 20, experts from the US Federal Centers for Disease Control and Prevention began an investigation into the death of an American woman.
It is noted that now there is no evidence confirming the version that thrombosis was directly related to vaccination against coronavirus. At the same time, according to the TV channel, the woman died within two weeks after the vaccination.
On April 13, US medical authorities recommended that the use of the Janssen vaccine be suspended due to potential side effects. In total, 6.8 million people were vaccinated with this drug in the United States, while the authorities recorded six cases of blood clots in women aged 18 to 48 years, 6-13 days after vaccination, one of the patients died. Within a day, the use of the drug was suspended in all states of the United States.